Our Investment Partner Katrin Vatiska co-chaired the “Future Patient’s Journey: Data & Diagnostics” panel alongside Rainer Metzger (Head of Integrated Clinical Services, Medicover) at the 11th Sachs Healthtech Investment Forum in Basel. They were joined by panelists Dr. Ali Tinazli (CEO, lifespin GmbH), Dr. Giancarlo Rizzoli (CEO, 4D Lifetec AG), Ruthy Kaidar (Managing Director Healthcare, EMEA, Microsoft), and Todor Jeliaskov (Chairman & CEO, inHEART). Key takeaway: "Multimodal data is essential for advancing AI in diagnostics. While significant progress has been made, there’s still room for improvement. Simplifying the language in patient release letters is one key step to enhance data collection and usability." Sachs Associates #Sachs_HTIF #AI #healthtech #healthtechinvestment
MTIP
Wagniskapital- und Private-Equity-Auftraggeber
MTIP is a leading growth equity firm investing in healthtech companies that aim to revolutionize global healthcare
Info
MTIP ist ein wachsender paneuropäischer Healthtech Growth Capital Investor mit Sitz in Basel, Schweiz. Wir investieren in Unternehmen der digitalen Gesundheit und der digital vernetzten Medizintechnik, deren Angebote einen klaren gesundheitsbezogenen und wirtschaftlichen Nutzen anbieten. Unser Investmentteam, das über umfassende Private-Equity-Kenntnissen verfügt, arbeitet aktiv mit unseren Portfoliounternehmen zusammen, um deren Wachstum zu fördern. MTIP setzt das Kapital effizient ein, um Werte freizusetzen und attraktive Renditen für unsere Investoren zu erzielen.
- Website
-
http://www.mtip.ch
Externer Link zu MTIP
- Branche
- Wagniskapital- und Private-Equity-Auftraggeber
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Basel
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2014
- Spezialgebiete
- Healthcare, Digital Health, Healthcare systems, Healthtech, Growth Capital, Private Equity und Medical Technologies
Orte
-
Primär
Rittergasse 35
Basel, 4051, CH
Beschäftigte von MTIP
Updates
-
Are you interested in learning more about the #impact of our portfolio companies? 💡 With a focus on healthtech innovation, we’re empowering companies that are making a real-world difference by addressing healthcare inequality. Learn more about how we measure success through the AAAQ framework and how our portfolio is delivering both social impact and financial returns in the latest issue of Real Deals magazine: https://lnkd.in/gYXy_prH #HealthtechInnovation #ImpactInvesting #Healthtech #Sustainability #ImpactTracker #ESG
-
Last week, we hosted our annual MTIP Healthcare Clinic at the Teufelhof in Basel, bringing together our community of investors, friends, and business partners. The event featured insightful updates from MTIP, deep dives into our portfolio companies, and discussions on key market developments. We extend our heartfelt thanks to our portfolio company speakers—Jochen Reinöhl, MD, MSc (Coramaze Technologies), Farzana Rahman, Sam Dumonteil (Hexarad), Bracy Fertig, and Bjoern von Siemens (Caresyntax)—as well as to all participants who contributed to making our clinic an outstanding success. Your engagement and enthusiasm were instrumental in creating a vibrant and productive atmosphere. We look forward to continuing these important conversations and fostering connections within the healthtech investment community! 💙 #MTIP #HealthcareClinic #Healthtech #AGM
-
2
-
MTIP is gearing up for Tech Tour Growth Health 2024! 🚀 Carmel van den Berk will be attending the conference in Lausanne and participating in a panel discussion this Wednesday morning. Carmel is excited to connect with old and new friends, founders, and investors throughout the event! #TechTour #TechTourGrowthHealth
-
MTIP’s Impact Report 2023 is out now! 🌍 As we continue to lead the way in sustainable healthtech investments, our commitment to fostering purpose-driven healthtech companies across Europe remains stronger than ever. By aligning impactful innovation with strong financial returns and leveraging our deep sector expertise, we empower these businesses to overcome challenges and achieve meaningful growth—one step at a time. Discover how our ongoing efforts in ESG and impact integration are driving value creation and building a more sustainable future for healthtech. Read the full report here: https://lnkd.in/d9aSDDwg #impactinvesting #impactreport #impactinvestment #esgintegration #healthtech
-
Join us in welcoming Lloyd Diamond as the new CEO of Nitinotes Surgical, bringing his extensive experience in medical devices to drive the company’s growth and innovation!
𝗪𝗲𝗹𝗰𝗼𝗺𝗶𝗻𝗴 𝗟𝗹𝗼𝘆𝗱 𝗗𝗶𝗮𝗺𝗼𝗻𝗱 𝗮𝘀 𝗼𝘂𝗿 𝗻𝗲𝘄 𝗖𝗘𝗢 We are excited to announce Lloyd Diamond as the new CEO of NITINOTES, leading our rapidly expanding operations into an innovative future. With over 30 years of leadership in the medical device industry, Lloyd has driven major advancements across orthopedics, endoscopic, and general surgical devices. His recent tenure as CEO of Pixium Vision S.A. saw the development of pioneering bionic vision systems and the cultivation of strategic partnerships. John Barr, our Chairman of the Board, shared his excitement: "We are thrilled to have Lloyd lead NITINOTES into its next chapter of growth and innovation. His profound experience in medical technologies makes him the ideal leader to propel our future initiatives." Lloyd succeeds Raz Bar-On, who will continue his crucial role as GM of NITINOTES Israel, overseeing our operations, R&D, and regulatory functions. "I am honored to join NITINOTES at this pivotal time," Lloyd shares. "With rising global obesity rates affecting over a billion people, our EndoZip™ provides a critical solution to a significant health challenge. I look forward to collaborating with our talented team to extend the reach of this groundbreaking solution to more patients and healthcare providers globally." As we gear up for pivotal trials in the U.S., we are also enhancing our operational capabilities to meet the increasing global demand and regulatory milestones, including the imminent CE mark approval and our European commercial launch. --------------- About Us: Nitinotes Surgical is at the forefront of medical technology, dedicated to innovating obesity treatment. Our flagship product, EndoZip™, revolutionizes the approach for Class I & II obesity patients by ensuring consistent, safe suturing at the press of a button—signifying a major leap forward in medical treatment options. https://lnkd.in/dWxeg35Y
-
Excited to welcome Daniela Nienstedt and Benjamin Gilgen to MTIP's Board of Directors! Daniela brings nearly 20 years of consulting experience with a strong focus on private capital, and Benjamin’s expertise in strategic marketing and innovation will be invaluable as MTIP continues its growth journey. Welcome aboard! ✨ Read the full press release here: https://lnkd.in/di6HFyW4 #boardmembers #growth #MTIP
-
We are pleased to announce MTIP Fund II’s ninth platform investment in Hexarad, leading the €13 million growth round with reinvestment from existing shareholders. Founded in 2016 and headquartered in London, UK, Hexarad’s radiology platform provides teleradiology services and software to customers in the UK, Ireland, and Saudi Arabia. Hexarad’s software suite covers an end-to-end radiology workflow including a proprietary radiology information system (RIS), Hexarad Edge integration engine, Hexarad Hub for urgent reporting and Hexarad Portal for auto-allocation. The teleradiology services offering provides teleradiology readings to the NHS and imaging centers across the UK and Ireland. The company has consistently achieved over 120% annual growth. Katrin Vatiska, Investment Partner at MTIP states: “We are highly impressed by the founding team—Farzana Rahman, Sam Dumonteil, Jaymin Patel, and Amy Davis—and we are excited to partner with them for the next phase of growth. We see tremendous potential in Hexarad and are thrilled to support the scaling of their teleradiology services and the expansion of their software product offerings.” Our €13 million investment will help Hexarad scale and solidify its position as the leading teleradiology services and software provider. Read the full press release here: https://lnkd.in/dRUCsH2i #teleradiology #healthtech #portfoliocompany #newinvestment
-
MTIP Featured in PEI’s 2024 Healthcare Report 🩵 Artificial Intelligence is reshaping the landscape of healthtech investing, offering unprecedented opportunities for innovation and efficiency. At MTIP, we are proud to support companies that are at the forefront of this AI-driven revolution ✨ Our Managing Partner & Co-Founder, Christoph Kausch, was interviewed for this article, providing valuable insights into the strategic approaches necessary for success in this evolving field. Discover more about how AI is driving the future of healthcare in our latest feature in Private Equity International’s 2024 Healthcare report. Click the link below to read the full article 🔗 #HealthcareInnovation #AI #PrivateEquity #DigitalHealth #Healthtech #HealthtechInvesting
How AI is reframing PE healthcare investing
privateequityinternational.com
-
Carmel van den Berk Promoted to Investment Associate ✨ We are excited to share the news of Carmel's promotion to Investment Associate. Since joining MTIP in October 2023, Carmel has significantly contributed to our team. She has played a crucial role in evaluating investment opportunities and in supporting and bringing value to our portfolio companies. We look forward to Carmel's continued achievements! 🩵 Check out her profile here: https://lnkd.in/dDHBXdSg #MTIPteam #promotion #investmentteam